Form 8-K - Current report:
SEC Accession No. 0001019687-04-001384
Filing Date
2004-06-21
Accepted
2004-06-21 14:08:10
Documents
3
Period of Report
2004-06-21
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 titan_8k-062104.htm 8-K 8522
2 titan_8kex99-1.htm EX-99.1 5394
3 GRAPHIC titan_8k.jpg GRAPHIC 32850
  Complete submission text file 0001019687-04-001384.txt   48574
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 04872283
SIC: 2836 Biological Products, (No Diagnostic Substances)